Table 4 Follow-up plan and collection of patient data
Enrolment allocation | Intervention group: | ||
15 HC selected from those participating in ESCARVAL-risk study. | |||
350 patients randomly selected from the total amount of patients with IHD registered in the electronic health records. | |||
Patients are enrolled by their primary care physicians. (Inclusion and exclusion criteria). | |||
Control group: | |||
A random sample of patients (350) with IHD selected from 72 HC electronic records (from ESCARVAL-risk study) | |||
Intervention follow-up: 1 year | Baseline data | ||
Personalized follow-up record | |||
Starting formative intervention strategy for professionals and patients: | |||
Intervention | Patients | Professionals | |
First visit | Evaluate monitoring of CVRF | Advice online by cardiologist | |
Accord control objectives | Monthly updates | ||
Adherence control | Protocols, guides and bibliography reviews | ||
Therapeutic education | In-class training course | ||
Second visit | Evaluate monitoring of CVRF | Advice online by cardiologist | |
Accord control objectives | Monthly updates | ||
Adherence control | Protocols, guides and bibliography reviews | ||
Therapeutic education | In-class training course | ||
Third visit | Evaluate monitoring of CVRF | Advice online by cardiologist | |
Accord control objectives | Monthly updates | ||
Adherence control | Protocols, guides and bibliography reviews | ||
Therapeutic education | In-class training course | ||
Number of hospital admissions | |||
Outcomes | Statistical analysis. Loses to follow-up. | ||
Presentation of results at participating HC. | |||
Final report | |||